Johnson & Johnson (JNJ) Stock: Surge as FDA Clearance Boosts MONARCH QUEST 3 Expansion
TLDR JNJ stock gains as FDA clears MONARCH QUEST 3 bronchoscopy software update. MONARCH QUEST 3 adds AI-powered planning and stronger navigation capabilities. Johnson & Johnson expands CBCT








